Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Observation
|
Mid-range Performer
1999.1000
-7.90
(
-0.39
%)
NSE
Sep 24, 2025
14:27 PM
Volume:
269.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
07 Aug 2025
US FDA Observation
1999.10
-0.39%
Result Update:Lupin
Buy:
Lupin Ltd.
by
Axis Direct
Target: 2400 | Upside : 20.1%
Target
Axis Direct
We recommend a BUY rating with a target price of Rs 2,500/share.
Lupin Ltd. is trading
above its 150 day SMA
of 1980.2
More from Lupin Ltd.
Recommended
Market trades lower, NTPC seeks government approval to acquire nuclear reactors
Trendlyne Marketwatch |
24 Sep 2025, 02:29PM
Five stocks to buy from analysts this week - September 23, 2025
The Baseline |
23 Sep 2025, 06:11PM
Lupin expects normalization by September quarter
|
17 Apr 2020